Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
BPC 157 promotes the repair of skin and other tissues after injury by supporting signals that tell cells to grow and repair themselves
Specific dosing parameters vary significantly between studies and animal models researchers should reference the primary literature for protocol design
[8] Novo Nordisk announced late at the 2025 European Association for the Study of Diabetes (EASD) annual meeting that in the REDEFINE 1 study, [9] cagrilintide provided clinically significant weight loss, with a mean reduction in body weight of 11.8% compared to 2.3% with placebo after 68 weeks, considering adherence of all participants to treatment
Whether its optimizing performance, stabilizing conditions, or facilitating healing, we leverage the therapeutic potential of BPC-157 to support your goals
This isn't about selling you a treatment
The authors identified future areas of investigation including male models, long-term treatment effects, and combination with other NAD+ precursors such as NMN
US$ 23.58
US$ 24.39
US$ 25.64
US$ 24.09
US$ 21.74
US$ 22.15
US$ 23.66
US$ 29.93
US$ 26.70
